Consistent with the WHO recommendation, Faberco Life Sciences Inc. has recently made available GC FLU Trivalent Influenza Vaccine (split virion, inactivated) pre-filled syringe injection containing three influenza virus strains (Type A Victoria/H1N1, Type A Croatia/H3N2, and Type B Austria) for the 2025 influenza season.

It is indicated for the active immunization of adults and children from 6 months of age and older against influenza, specifically targeting strains currently circulating in the Philippines.

GC Flu is formulated to match the influenza strains circulating in the country, ensuring optimal protection against influenza disease.